Printer Friendly

NEWVISION ANNOUNCES JOHN D. HUNKELER, M.D. JOINS BOARD OF DIRECTORS

 BURLINGTON, Mass., Oct. 7 /PRNewswire/ -- NewVision Technology, Inc. (NASDAQ: VISN) announced today that John D. Hunkeler, M.D. was elected to the board of directors on Oct. 1, 1993.
 Hunkeler is a graduate of Harvard University and the University of Kansas School of Medicine. He currently is Clinical Associate Professor of Ophthalmology at the University of Kansas Medical Center and is the founder of the Hunkeler Eye Clinic in Kansas City, Mo., specializing in cataract and refractive surgery. The Hunkeler Eye Clinic also serves as a national training center for ophthalmologists interested in learning about excimer laser applications for refractive surgery. An internationally recognized leader in ophthalmology, Hunkeler was the first surgeon in the United States to use the excimer laser for refractive correction in a sighted human eye. As national medical monitor for a Food and Drug Administration (FDA) photorefractive keratectomy (PRK) study, Hunkeler continues his leadership role. In addition, he is involved in several other ongoing FDA clinical studies within ophthalmology.
 Hunkeler was the founding director of the Kansas City Eye Bank and served as medical director for 10 years. He has held leadership roles in many ophthalmic organizations and serves on the boards of the Outpatient Ophthalmic Surgery Society, the American Board of Eye Surgery and the Society for Geriatric Ophthalmology. He is also a past board member of the Eye Bank Association of America.
 As the current President of the American Society of Cataract and Refractive Surgery, Hunkeler is at the forefront of regulatory, technological, and practice-related developments in ophthalmology.
 "Dr. Hunkeler's contributions to ophthalmology in general, and excimer laser technology in particular, are well known to everyone involved in this industry. His addition to the NewVision Board of Directors brings us additional knowledge and leadership very specific to our business," stated Stephen M. Blinn, executive vice president and COO of NewVision. "His understanding of, and personal participation in, the U.S. Ophthalmic Community will be extremely valuable in defining the direction of the company as excimer laser technology moves towards FDA approval."
 NewVision has established Laser Refractive Surgery Centers pursuant to the company's joint venture agreement with British United Provident Association (BUPA) within certain BUPA healthcare facilities in the United Kingdom. These centers utilize excimer lasers and a technique called PRK to correct common vision disorders such as nearsightedness, farsightedness and astigmatism now being treated with eyeglasses and contact lenses. The company plans to expand operations into the United States concurrently with FDA approval of refractive laser systems for PRK.
 The business of NewVision Technology, Inc. is to provide to its customers and partners in the ophthalmic and optometric community, the safest and most efficacious technologies and techniques, coupled with sophisticated marketing and promotional support, for the correction of common vision disorders and to share in the revenue generated through these partnerships.
 -0- 10/7/93
 /CONTACT: Paula Filias, investor relations of NewVision Technology, 617-229-1100/
 (VISN VISNW)


CO: NewVision Technology, Inc. ST: Massachusetts IN: MTC SU: PER

JL-DD -- NE003 -- 9618 10/07/93 08:28 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 7, 1993
Words:501
Previous Article:CHUBB LIFE RECEIVES NATIONAL ART AWARD
Next Article:COLDER THAN NORMAL TEMPERATURES IN THE U.S. DROVE HOME HEATING OIL DEMAND FOR SEPTEMBER, 44 PERCENT HIGHER THAN NORMAL ACCORDING TO PLATT'S
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters